Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Mass Tort Litigation & Settlement Strategies

Overview

As pioneers in mass tort litigation, we aggressively defend high-stakes mass tort cases and multidistrict litigation while focusing on your strategic and business priorities. With innovative management processes, we coordinate simultaneous federal and state court litigation, working effectively with corporate and local counsel. Using the virtual law team model, we organize into teams based on anticipated litigation activities, which serves your strategic and financial interests. We have the depth to play every role in mass tort litigation and the collaborative skills to work in concert with other firms in the United States or around the world. We develop long-term, parallel track litigation strategy, understanding that settlement ultimately may best align with your goals. Your definition of success drives our approach. To promote efficiency, we leverage technology to manage large case portfolios and mass settlements, and we partner with Tritura to streamline e-discovery, data preservation, information governance, and database management and to efficiently report to clients. With plaintiffs’ firms growing increasingly sophisticated, our record of handling tens of thousands of cases in major pharmaceutical, medical device, food, agribusiness, automobile, and consumer products litigation will help you sleep at night when facing mass tort litigation.

Insights & Events

Insights
Updates September 2026

Transposing the EU's New Product Liability Directive: A Member State Progress Report — September 2026 Updates

Croatia is now the second state to fully transpose the PLD into national law.
8 min read
Media Mentions August 2026

Norman Pentelovitch Discusses Strategic Client Counseling in Corporate Counsel Q&A Feature

1 min read
Updates August 2026

Second Circuit Adopts the Indirect Purchaser Rule for Civil RICO

5 min read
Podcast August 2026

Aaron Van Oort Discusses Eighth Circuit Court of Appeals With Short Circuit Podcast

1 min read
Media Mentions August 2026

Norman Pentelovitch Profiled in Minnesota Lawyer’s ‘Breaking the Ice’ Feature

1 min read
Updates August 2026

DC Circuit Upholds EPA's PFAS Hazardous Substance Designations under CERCLA: What In-House Counsel Need to Know

Chamber of Commerce of the United States of America v. EPA, No. 24-1193
2 min read
Media Mentions April 2026

Vance Wittie Weighs In on Supreme Court’s Military Contractor Decision in Bloomberg Law

1 min read
Published Articles April 2026

Expert Witness Practice in U.S. Drug and Medical Device Litigation

International Comparative Legal Guide – Drug & Medical Device Litigation 2026
1 min read
Updates February 2026

England & Wales Litigation Brief — 2025 in Review

Key Developments in Litigation and Arbitration
11 min read
Updates December 2025

Significant Drug & Device Developments of 2025

Drug & Device Companies Need to Be Vigilant and Nimble in Adapting to These Shifts
17 min read

Meet The Team

Meet The Full Mass Tort Litigation & Settlement Strategies Team